U.S. Celiac Disease Treatment Market Size & Outlook
U.S. celiac disease treatment market, 2018-2030 (US$M)
Related Markets
U.S. celiac disease treatment market highlights
- The U.S. celiac disease treatment market generated a revenue of USD 240.7 million in 2024 and is expected to reach USD 458.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.3% from 2025 to 2030.
- In terms of segment, vitamins & minerals was the largest revenue generating treatment in 2024.
- Gluten Degrading Enzymes is the most lucrative treatment segment registering the fastest growth during the forecast period.
Celiac disease treatment market data book summary
| Market revenue in 2024 | USD 240.7 million |
| Market revenue in 2030 | USD 458.1 million |
| Growth rate | 11.3% (CAGR from 2025 to 2030) |
| Largest segment | Vitamins & minerals |
| Fastest growing segment | Gluten Degrading Enzymes |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vitamins & Minerals, Gluten Degrading Enzymes, Symptomatic Treatment (Anti-inflammatory drugs, Antihistamines, others), Other Treatments |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Amgen Inc, Amneal Pharmaceuticals, Takeda Pharmaceutical Co Ltd, Hikma Pharmaceuticals PLC, Viatris Inc, Novartis AG ADR, BioLine Rx Ltd ADR |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.9% of the global celiac disease treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. celiac disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 8.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Celiac Disease Treatment Market Scope
Celiac Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. celiac disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to celiac disease treatment market will help companies and investors design strategic landscapes.
Vitamins & minerals was the largest segment with a revenue share of 39.88% in 2024. Horizon Databook has segmented the U.S. celiac disease treatment market based on vitamins & minerals, gluten degrading enzymes, symptomatic treatment (anti-inflammatory drugs, antihistamines, others), other treatments covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. celiac disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. celiac disease treatment market databook
-
Our clientele includes a mix of celiac disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. celiac disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. celiac disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. celiac disease treatment market size, by treatment, 2018-2030 (US$M)
U.S. Celiac Disease Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
